Code of Maryland Regulations (Last Updated: April 6, 2021) |
Title 10. Maryland Department of Health |
Part 4. |
Subtitle 34. BOARD OF PHARMACY |
Chapter 10.34.35. Infusion Pharmacy Services in an Alternate Site Care Environment |
Sec. 10.34.35.08. Performance Improvement Program
-
A. The performance improvement program shall consist of:
(1) A committee which:
(a) Consists of representation of personnel and varied areas of job responsibility; and
(b) Is responsible for analysis of data, reporting trends and corrective actions; and
(c) Meets at least quarterly;
(2) Quality assurance and performance improvement monitoring parameters;
(3) Documentation requirements for:
(a) Established monitoring parameters;
(b) Trend analyses; and
(c) Retention of committee meeting minutes for 3 years;
(5) Documentation of tracking, trending, analyzing, resolving, and developing corrective action plans as appropriate for:
(a) Medication errors;
(b) Adverse drug reactions; and
(c) Equipment malfunctions;
(6) Reporting of adverse events to regulatory and standard-setting bodies as applicable to State and federal regulations;
(7) Documentation and resolution of patient care issues involving:
(a) Incorrect equipment, supplies, or medications;
(b) Delays in delivery of care;
(c) Missed doses;
(d) Patient infections;
(e) Failures in after-hours care; and
(f) Patient, caregiver, or health care provider complaints;
(8) Documentation of patient outcomes;
(9) Recall management;
(10) Patient compliance monitoring; and
(11) Staff training and competency compliance.
B. The permit holder shall review the performance improvement program at a minimum of every 3 years.